The DOI matches its Crossref record; 307 of the 307 references it cites were found in a registry or an index.
Drosophila as an In Vivo Model for Human Neurodegenerative Disease
Open accessAbstract
With the increase in the ageing population, neurodegenerative disease is devastating to families and poses a huge burden on society. The brain and spinal cord are extraordinarily complex: they consist of a highly organized network of neuronal and support cells that communicate in a highly specialized manner. One approach to tackling problems of such complexity is to address the scientific questions in simpler, yet analogous, systems. The fruit fly, Drosophila melanogaster, has been proven tremendously valuable as a model organism, enabling many major discoveries in neuroscientific disease research. The plethora of genetic tools available in Drosophila allows for exquisite targeted manipulation of the genome. Due to its relatively short lifespan, complex questions of brain function can be addressed more rapidly than in other model organisms, such as the mouse. Here we discuss features of the fly as a model for human neurodegenerative disease. There are many distinct fly models for a range of neurodegenerative diseases; we focus on select studies from models of polyglutamine disease and amyotrophic lateral sclerosis that illustrate the type and range of insights that can be gleaned. In discussion of these models, we underscore strengths of the fly in providing understanding into mechanisms and pathways, as a foundation for translational and therapeutic research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–307 of 307
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy
Mercuri, E., Bertini, E., Messina, S., Solari, A., D'Amico, A., Angelozzi, C., Battini, R., Berardinelli, A., Boffi, P., Bruno, C., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000249142.82285.d6 · Cited by 172
Ataxin-2 repeat-length variation and neurodegeneration
Ross, O. A., Rutherford, N. J., Baker, M., Soto-Ortolaza, A. I., Carrasquillo, M. M., DeJesus-Hernandez, M., Adamson, J., Li, M., Volkening, K., Finger, E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr227 · Cited by 172
Valor, L., Viosca, J., Lopez-Atalaya, J., & Barco, A. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990382 · Cited by 172
Phosphorylation of Threonine 3
Aiken, C. T., Steffan, J. S., Guerrero, C. M., Khashwji, H., Lukacsovich, T., Simmons, D., Purcell, J. M., Menhaji, K., Zhu, Y.-Z., Green, K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013193 · Cited by 171
Romero, E., Cha, G.-H., Verstreken, P., Ly, C. V., Hughes, R. E., Bellen, H. J., & Botas, J. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.025 · Cited by 170
Mutsuddi, M., Marshall, C. M., Benzow, K. A., Koob, M. D., & Rebay, I. (2004) · Current Biology · doi:10.1016/j.cub.2004.01.034 · Cited by 169
Chakraborty, R., Vepuri, V., Mhatre, S. D., Paddock, B. E., Miller, S., Michelson, S. J., Delvadia, R., Desai, A., Vinokur, M., Melicharek, D. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020799 · Cited by 169
Shulman, J. M., Imboywa, S., Giagtzoglou, N., Powers, M. P., Hu, Y., Devenport, D., Chipendo, P., Chibnik, L. B., Diamond, A., Perrimon, N., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt478 · Cited by 167 · cited 2×
“…within a GWAS region in a disease model: whereas the human data identifies genomic regions of interest, coupling that with fly genetics to examine functional interactions can narrow down gene targets to reveal those with the potential to have an impact on the disease process (Shulman et al. 2014).”
BackgroundNedelsky, N. B., Pennuto, M., Smith, R. B., Palazzolo, I., Moore, J., Nie, Z., Neale, G., & Taylor, J. P. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.034 · Cited by 166
Trinh, K., Moore, K., Wes, P. D., Muchowski, P. J., Dey, J., Andrews, L. A., & Pallanck, L. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4778-07.2008 · Cited by 165
HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones
Vos, M. J., Zijlstra, M. P., Kanon, B., van Waarde-Verhagen, M. A. W. H., Brunt, E. R. P., Oosterveld-Hut, H. M. J., Carra, S., Sibon, O. C. M., & Kampinga, H. H. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq398 · Cited by 165
Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS
Estes, P. S., Boehringer, A., Zwick, R., Tang, J. E., Grigsby, B., & Zarnescu, D. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr124 · Cited by 164
A Drosophila Model for Amyotrophic Lateral Sclerosis Reveals Motor Neuron Damage by Human SOD1
Watson, M. R., Lagow, R. D., Xu, K., Zhang, B., & Bonini, N. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804817200 · Cited by 163
Self-citationIdentification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila
Agrawal, N., Pallos, J., Slepko, N., Apostol, B. L., Bodai, L., Chang, L.-W., Chiang, A.-S., Thompson, L. M., & Marsh, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500055102 · Cited by 162
Mackenzie, I. R. A., & H. Feldman, H. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000174335.27708.0a · Cited by 161
Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila
Chan, H. Y. E. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2895 · Cited by 161
Vacher, C., Garcia-Oroz, L., & Rubinsztein, D. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi372 · Cited by 160
Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain
Pearce, M. M. P., Spartz, E. J., Hong, W., Luo, L., & Kopito, R. R. (2015) · Nature Communications · doi:10.1038/ncomms7768 · Cited by 159
Diaper, D. C., Adachi, Y., Sutcliffe, B., Humphrey, D. M., Elliott, C. J. H., Stepto, A., Ludlow, Z. N., Vanden Broeck, L., Callaerts, P., Dermaut, B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt005 · Cited by 159
Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS
Yamakawa, M., Ito, D., Honda, T., Kubo, K., Noda, M., Nakajima, K., & Suzuki, N. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu576 · Cited by 158
Rajendra, T. K., Gonsalvez, G. B., Walker, M. P., Shpargel, K. B., Salz, H. K., & Matera, A. G. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610053 · Cited by 158
Fossgreen, A., Brückner, B., Czech, C., Masters, C. L., Beyreuther, K. T., & Paro, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13703 · Cited by 156
Lush, M. J., Li, Y., Read, D. J., WILLIS, A. C., & Glynn, P. (1998) · Biochemical Journal · doi:10.1042/bj3320001 · Cited by 150
Lu, Y., Ferris, J., & Gao, F. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-30 · Cited by 145
RAS–MAPK–MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1
Park, J., Al‐Ramahi, I., Tan, Q., Mollema, N., Diaz-García, J. R., Gallego‐Flores, T., Lu, H., Lagalwar, S., Duvick, L. A., Kang, H., et al. (2013) · Nature · doi:10.1038/nature12204 · Cited by 142
Pilot trial of phenylbutyrate in spinal muscular atrophy
Mercuri, E. M., Bertini, E., Messina, S., Pelliccioni, M., D’Amico, A., Colitto, F., Massimiliano Mirabella, A., Tiziano, F. D., Vitali, T., Angelozzi, C., et al. (2003) · Neuromuscular Disorders · doi:10.1016/j.nmd.2003.11.006 · Cited by 141
Rab11a and HSP90 Regulate Recycling of Extracellular α-Synuclein
Liu, J., Zhang, J., Shi, M. Y., Quinn, T. J., Bradner, J. M., Beyer, R., Chen, S., & Zhang, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6202-08.2009 · Cited by 137
de Haro, M., Al‐Ramahi, I., Gouyon, B., Ukani, L., Rosa, A. L., Faustino, N. A., Ashizawa, T., Cooper, T. A., & Botas, J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl137 · Cited by 137
Satterfield, T. F., Jackson, S. M., & Pallanck, L. J. (2002) · Genetics · doi:10.1093/genetics/162.4.1687 · Cited by 135
Ubiquilin Modifies TDP-43 Toxicity in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS)
Hanson, K. A., Kim, S. H., Wassarman, D. A., & Tibbetts, R. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.078527 · Cited by 133
Kissel, J. T., Scott, C., Reyna, S. P., Crawford, T. O., Simard, L. R., Krosschell, K. J., Acsádi, G., Elsheik, B., Schroth, M. K., D’Anjou, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021296 · Cited by 131
Takahashi, M., Kanuka, H., Fujiwara, H., Koyama, A., Hasegawa, M., Miura, M., & Iwatsubo, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01258-2 · Cited by 129
Xia, R., Liu, Y., Yang, L., Gál, J., Zhu, H., & Jia, J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-10 · Cited by 129
Haacke, A., Broadley, S. A., Boteva, R. N., Tzvetkov, N., Hartl, F. U., & Breuer, P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi472 · Cited by 128
Ratnaparkhi, A., Lawless, G. M., Schweizer, F. E., Golshani, P., & Jackson, G. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002334 · Cited by 122
Batulan, Z., Taylor, D. M., Aarons, R. J., Minotti, S., Doroudchi, M. M., Nalbantoglu, J. N., & Durham, H. D. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.017 · Cited by 117
Cao, W., Song, H., Gangi, T., Kelkar, A., Antani, I., Garza, D., & Konsolaki, M. (2008) · Genetics · doi:10.1534/genetics.107.078394 · Cited by 115
Elefant, F., & Palter, K. B. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.7.2101 · Cited by 114
Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113 · cited 1×
“…(TDP-43) Chen et al. (2009); Ambegaokar and Jackson (2010); Elden et al. (2010); Hanson et al. (2010); Ritson et al. (2010); Voigt et al. (2010); Ambegaokar and Jackson (2011); Estes et al. (2011); Miguel et al. (2012) VABP Chai et al. (2008); Ratnaparkhi et al. (2008); Chen et al. (2010) VCP…”
Hsp104: A Weapon to Combat Diverse Neurodegenerative Disorders
Shorter, J. (2007) · Neurosignals · doi:10.1159/000109760 · Cited by 113
Expression of human FUS protein in Drosophila leads to progressive neurodegeneration
Chen, Y., Yang, M., Deng, J., Chen, X., Ye, Y., Zhu, L., Liu, J., Ye, H., Shen, Y., Li, Y., et al. (2011) · Protein & Cell · doi:10.1007/s13238-011-1065-7 · Cited by 113
TDP-43 Phosphorylation by casein kinase Iε promotes oligomerization and enhances toxicity in vivo
Choksi, D. K., Roy, B., Chatterjee, S., Yusuff, T., Bakhoum, M. F., Sengupta, U., Ambegaokar, S. S., Kayed, R., & Jackson, G. R. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt498 · Cited by 111
Evers, M. M., Toonen, L. J. A., & van Roon‐Mom, W. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8596-2 · Cited by 109
Caspase‐mediated proteolysis of the polyglutamine disease protein ataxin‐3
Berke, S. J. S., Schmied, F. A. F., Brunt, E. R. P., Ellerby, L., & Paulson, H. L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02369.x · Cited by 108
Ye, Y., & Fortini, M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.6.1351 · Cited by 107
Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Tanaka, F., Doyu, M., & Sobue, G. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0066-0 · Cited by 107
Probing Mechanisms That Underlie Human Neurodegenerative Diseases in Drosophila
Jaiswal, M., Sandoval, H., Zhang, K., Bayat, V., & Bellen, H. J. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155456 · Cited by 106
From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease
Shulman, J. M., Shulman, L. M., Weiner, W. J., & Feany, M. Β. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000084220.82329.60 · Cited by 106
Chai, A., Withers, J., Koh, Y. H., Parry, K., Bao, H., Zhang, B., Budnik, V., & Pennetta, G. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm303 · Cited by 103
Zhang, S., Feany, M. Β., Saraswati, S., Littleton, J. T., & Perrimon, N. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.000653 · Cited by 101
Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis
Conforti, F. L., Spataro, R., Sproviero, W., Mazzei, R., Cavalcanti, F., Condino, F., Simone, I. L., Logroscino, G., Patitucci, A., Magariello, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318278b618 · Cited by 94
Thomas, M., Harrell, J. M., Morishima, Y., Peng, H., Pratt, W. B., & Lieberman, A. P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl110 · Cited by 94
Latouche, M., Lasbleiz, C., Martin, E., Monnier, V., Debeir, T., Prigent, A., Muriel, M., Morel, L. J., Ruberg, M., Brice, A., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5453-06.2007 · Cited by 92
A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity
Verma, P., Augustine, G. J., Ammar, M.-R., Tashiro, A., & Cohen, S. M. (2015) · Nature Neuroscience · doi:10.1038/nn.3935 · Cited by 91
Houseley, J. M., Wang, Z., Brock, G., Soloway, J. R., Artero, R. D., Pérez‐Alonso, M., O’Dell, K. M. C., & Monckton, D. G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi080 · Cited by 89
Kitson, R. R. A., Chang, C., Xiong, R., Williams, H. E. L., Davis, A. L., Lewis, W., Dehn, D. L., Siegel, D. M., Roe, S. M., Prodromou, C., et al. (2013) · Nature Chemistry · doi:10.1038/nchem.1596 · Cited by 88
Neuronal Function and Dysfunction of Drosophila dTDP
Lin, M.-J., Cheng, C.-W., & Shen, C. ‐. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020371 · Cited by 87
Gispert, S., Kurz, A., Waibel, S., Bauer, P., Liepelt, I., Geisen, C., Gitler, A. D., Becker, T., Weber, M., Berg, D., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.021 · Cited by 86
Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model
Cushman-Nick, M., Bonini, N. M., & Shorter, J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003781 · Cited by 80
Self-citationKissel, J. T., Elsheikh, B., King, W. M., Freimer, M. L., Scott, C., Kolb, S. J., Reyna, S. P., Crawford, T. O., Simard, L. R., Krosschell, K. J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23904 · Cited by 79
Interference of human and Drosophila APP and APP‐like proteins with PNS development in Drosophila
Merdes, G., Soba, P., Loewer, A., Bilic, M. V., Beyreuther, K. T., & Paro, R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600413 · Cited by 79
Min, K., & Benzer, S. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00378-2 · Cited by 79
Amyloid precursor protein-induced axonopathies are independent of amyloid-β peptides
Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., Lillo, C., Mount, S. L., Roberts, E. A., McGowan, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn240 · Cited by 78 · cited 1×
“This finding Alzheimer’s disease models APP Fossgreen et al. (1998); Greeve et al. (2004); Merdes et al. (2004); Muhammad et al. (2008); Stokin et al. (2008); Chakraborty et al. (2011); Mhatre et al. (2014) A-beta peptide Finelli et al. (2004); Iijima et al. (2004); Cao et al. (2008) PSEN 1 and 2…”
Venken, K. J. T., & Bellen, H. J. (2014) · Methods · doi:10.1016/j.ymeth.2014.02.025 · Cited by 78
Ataxin‐1 and Brother of ataxin‐1 are components of the Notch signalling pathway
Tong, X., Gui, H., Jin, F. J., Heck, B. W., Lin, P., Ma, J., Fondell, J. D., & Tsai, C. (2011) · EMBO Reports · doi:10.1038/embor.2011.49 · Cited by 78
DnaJB6 is present in the core of Lewy bodies and is highly up‐regulated in parkinsonian astrocytes
Durrenberger, P. F., Filiou, M. D., Moran, L. B., Michael, G. J., Novoselov, S. S., Cheetham, M. E., Clark, P., Pearce, R. K. B., & Graeber, M. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21819 · Cited by 76
Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23
Blount, J. R., Tsou, W., Ristic, G., Burr, A. A., Ouyang, M., Galante, H., Scaglione, K. M., & Todi, S. V. (2014) · Nature Communications · doi:10.1038/ncomms5638 · Cited by 76
Kuo, Y., Ren, S., Lao, U., Edgar, B. A., & Wang, T. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.351 · Cited by 75
Roy, B., & Jackson, G. R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu011 · Cited by 75
ATXN2 polyQ intermediate repeats are a modifier of ALS survival
Chiò, A., Calvo, A., Moglia, C., Canosa, A., Brunetti, M., Barberis, M., Restagno, G., Conte, A., Bisogni, G., Marangi, G., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001159 · Cited by 74
Broeck, L. V., Naval-Sánchez, M., Adachi, Y., Diaper, D. C., Dourlen, P., Chapuis, J., Kleinberger, G., Gistelinck, M., Broeckhoven, C. V., Lambert, J., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.014 · Cited by 71
New research resources at the Bloomington Drosophila Stock Center
Cook, K. R., Parks, A. L., Jacobus, L. M., Kaufman, T. C., & Matthews, K. (2010) · Fly · doi:10.4161/fly.4.1.11230 · Cited by 66
McGurk, L., Lee, V. M., Trojanowksi, J. Q., Deerlin, V. M. V., Lee, E. B., & Bonini, N. M. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000102 · Cited by 64
Self-citationPrevalence of Amyotrophic Lateral Sclerosis — United States, 2010–2011
(2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302747 · Cited by 64
Clinical and biochemical correlates of insoluble α-synuclein in dementia with Lewy bodies
Klucken, J., Ingelsson, M., Shin, Y., Irizarry, M. C., Hedley‐Whyte, E. T., Frosch, M. P., Growdon, J. H., McLean, P. J., & Hyman, B. T. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0027-7 · Cited by 62
Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila
Miguel, L., Avequin, T., Delarue, M., Feuillette, S., Frébourg, T., Campion, D., & Lecourtois, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.008 · Cited by 62
Neurodegeneration by polyglutamine Atrophin is not rescued by induction of autophagy
Nisoli, I., Chauvin, J., Napoletano, F., Calamita, P., Zanin, V., Fanto, M., & Charroux, B. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.31 · Cited by 61
What's wrong with epigenetics in Huntington's disease?
Valor, L. M., & Guiretti, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.025 · Cited by 61
Sang, T., Li, C., Liu, W., Rodríguez, A., Abrams, J., Zipursky, S. L., & Jackson, G. R. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi032 · Cited by 60
Gavin, B. A., Dolph, M. J., Deleault, N. R., Geoghegan, J. C., Khurana, V., Feany, M. Β., Dolph, P. J., & Supattapone, S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3372-06.2006 · Cited by 58
Motor neuron disease and dementia reported among 13 members of a single family
Gunnarsson, L., Dahlbom, K., & Strandman, E. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04983.x · Cited by 56
Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3
Jung, J., Xu, K., Lessing, D., & Bonini, N. M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp456 · Cited by 56
Self-citationMechanistic Studies on Hsp90 Inhibition by Ansamycin Derivatives
Onuoha, S. C., Mukund, S. R., Coulstock, E. T., Sengerová, B., Shaw, J. S., McLaughlin, S. H., & Jackson, S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.065 · Cited by 55
Expression of human FALS SOD in motorneurons of Drosophila
Elia, A., Parkes, T. L., Kirby, K., George‐Hyslop, P. S., Boulianne, G.-H. L., Phillips, J. P., & Hilliker, A. J. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00333-5 · Cited by 51
Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?
van den Heuvel, D. M. A., Harschnitz, O., van den Berg, L. H., & Pasterkamp, R. J. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.09.001 · Cited by 50
Lee, S. B., Bagley, J. A., Lee, H. Y., Jan, L. Y., & Jan, Y. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113573108 · Cited by 49
Modeling Clinically Heterogeneous Presenilin Mutations with Transgenic Drosophila
Seidner, G. A., Ye, Y., Faraday, M. M., Alvord, W. G., & Fortini, M. (2006) · Current Biology · doi:10.1016/j.cub.2006.04.004 · Cited by 47
Liu, X., Lu, M., Tang, L., Zhang, N., Chui, D., & Fan, D. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.009 · Cited by 47
Chen, Y., Huang, R., Yang, Y., Chen, K., Song, W., Pan, P., Li, J., & Shang, H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.015 · Cited by 43
Bier, E., & Reiter, L. T. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.3.387 · Cited by 43
Conditional expression of UAS‐transgenes in the adult eye with a new gene‐switch vector system
Roman, G., & Davis, R. L. (2002) · genesis · doi:10.1002/gene.10133 · Cited by 42
Cas9-Based Genome Editing in Drosophila
Housden, B. E., Lin, S., & Perrimon, N. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801185-0.00019-2 · Cited by 41
Prion-induced toxicity in PrP transgenic Drosophila
Thackray, A. M., Muhammad, F., Zhang, C., Denyer, M., Spiropoulos, J., Crowther, D. C., & Bujdoso, R. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.01.005 · Cited by 40
Tazen, S., Figueroa, K. P., Kwan, J. Y., Goldman, J. S., Hunt, A. L., Sampson, J. B., Gutmann, L., Pulst, S. M., Mitsumoto, H., & Kuo, S. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.443 · Cited by 39
-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila
Poças, G. M., Branco‐Santos, J., Herrera, F., Outeiro, T. F., & Domingos, P. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu606 · Cited by 38
Mhatre, S. D., Michelson, S. J., Gomes, J., Tabb, L. P., Saunders, A. J., & Marenda, D. R. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.08.021 · Cited by 37
Compound heterozygous PNPLA6 mutations cause Boucher–Neuhäuser syndrome with late-onset ataxia
Deik, A., Johannes, B. A., Rucker, J. C., Sánchez, E., Brodie, S. E., Deegan, E. M., Landy, K., Kajiwara, Y., Scelsa, S. N., Saunders-Pullman, R. J., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7516-3 · Cited by 36
Jackson, S. M., Whitworth, A. J., Greene, J. C., Libby, R. T., Baccam, S. L., Pallanck, L. J., & Spada, A. R. L. (2005) · Gene · doi:10.1016/j.gene.2004.12.008 · Cited by 35
Deactivation of TBP contributes to SCA17 pathogenesis
Hsu, T.-C., Wang, C.-K., Yang, C.-Y., Lee, L.-C., Hsieh-Li, H.-M., Ro, L., Chen, C., Lee‐Chen, G., & Su, M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu410 · Cited by 35
Interaction Between Eye Pigment Genes and Tau-Induced Neurodegeneration in Drosophila melanogaster
Ambegaokar, S. S., & Jackson, G. R. (2010) · Genetics · doi:10.1534/genetics.110.119545 · Cited by 30
In Vivo Reconstitution of γ-Secretase in Drosophila Results in Substrate Specificity
Stempfle, D., Kanwar, R., Loewer, A., Fortini, M., & Merdes, G. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00030-10 · Cited by 26
CDK 5 protects from caspase‐induced Ataxin‐3 cleavage and neurodegeneration
Liman, J., Deeg, S., Voigt, A., Voßfeldt, H., Dohm, C. P., Karch, A., Weishaupt, J. H., Schulz, J. B., Bähr, M., & Kermer, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12684 · Cited by 21
Yu, Z., Goodman, L. D., Shieh, S.-Y., Ma, M., Teng, X., Zhu, Y., & Bonini, N. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu507 · Cited by 20
Self-citationSuppression of Polyglutamine Toxicity by the Yeast Sup35 Prion Domain in Drosophila
Li, L.-B., Xu, K., & Bonini, N. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705211200 · Cited by 15
Self-citationNishimura, Y., Yalgin, C., Akimoto, S., Doumanis, J., Sasajima, R., Nukina, N., Miyakawa, H., Moore, A. W., & Morimoto, T. (2010) · Journal of Neurogenetics · doi:10.3109/01677063.2010.514367 · Cited by 11
Bakhoum, M. F., & Jackson, G. R. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00011-x · Cited by 7
The Mechanism of Mendelian Heredity
(1916) · Nature · doi:10.1038/097117a0 · Cited by 2
Cited by
Pohl, F., & Kong Thoo Lin, P. (2018) · Molecules · doi:10.3390/molecules23123283 · Cited by 272
Marquez-Lona, E. M., Torres-Machorro, A. L., Gonzales, F. R., Pillus, L., & Patrick, G. N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179893 · Cited by 17
Retromer deficiency in Tauopathy models enhances the truncation and toxicity of Tau
Asadzadeh, J., Ruchti, E., Jiao, W., Limoni, G., MacLachlan, C., Small, S. A., Knott, G., Santa-Maria, I., & McCabe, B. D. (2022) · Nature Communications · doi:10.1038/s41467-022-32683-5 · Cited by 14
Bülow, M. H., Parsons, B. D., & Di Cara, F. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-60204-8_11 · Cited by 8
Chakraborty, A., Devarajan, A., Kumar, K., C. S., R., Madhusudhan, M. S., Ratnaparkhi, G. S., & Kamat, S. S. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00865 · Cited by 4
Metadata
- Authors
- McGurk, L., Berson, A., & Bonini, N. M.
- Venue
- Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-01
- Volume
- 201
- Issue
- 2
- Pages
- 377-402
- ISSN
- 0016-6731 (ISSN-L)
- 1943-2631
- OpenAlex
- W2210338528
- Cited by
- 318
- References
- 307
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.